These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 22406996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Enhanced sensitivity of leukemia cell line KG-1a to activated immune cell-mediated cytolysis after treated with resveratrol].
    Hu L, Yang H, Li L, Zhang Z, Fang X, Cao D.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):645-9. PubMed ID: 25052611
    [Abstract] [Full Text] [Related]

  • 3. Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells.
    Lu X, Zhu A, Cai X, Jia Z, Han W, Ma L, Zhou M, Qian K, Cen L, Chen B.
    Cancer Biol Ther; 2012 Jun; 13(8):623-9. PubMed ID: 22555808
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C, Huenecke S, Suemmerer A, Erben S, Rettinger E, Pfirrmann V, Heinze A, Zimmermann O, Klingebiel T, Ullrich E, Bader P, Bremm M.
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.
    Sharma N, Trinidad CV, Trembath AP, Markiewicz MA.
    J Immunol; 2017 Oct 15; 199(8):2865-2872. PubMed ID: 28893955
    [Abstract] [Full Text] [Related]

  • 14. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
    Rettinger E, Kuçi S, Naumann I, Becker P, Kreyenberg H, Anzaghe M, Willasch A, Koehl U, Bug G, Ruthardt M, Klingebiel T, Fulda S, Bader P.
    Cytotherapy; 2012 Jan 15; 14(1):91-103. PubMed ID: 21973023
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility.
    Luis Espinoza J, Takami A, Trung LQ, Nakao S.
    Cancer Sci; 2013 Jun 15; 104(6):657-62. PubMed ID: 23445485
    [Abstract] [Full Text] [Related]

  • 20. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI, Jave-Suarez LF, Ortiz-Lazareno PC, Bravo-Cuellar A, Gonzalez-Ramella O, Aguilar-Lemarroy A, Hernandez-Flores G, Pereira-Suarez AL, Daneri-Navarro A, del Toro-Arreola S.
    BMC Immunol; 2012 Feb 08; 13():7. PubMed ID: 22316211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.